1,000-Patient study to decode widespread artery disease

NCT ID NCT07151183

Recruiting now Knowledge-focused Sponsor: Jinwei Tian Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study will collect DNA samples and medical records from 1,000 people with panvascular disease, a condition where arteries in multiple parts of the body are narrowed or blocked. Researchers will analyze this data to better understand what causes the disease and how it progresses. The goal is to improve diagnosis and find more effective treatments for conditions like heart attack, stroke, and peripheral artery disease.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this research could lead to better ways to diagnose and treat panvascular diseases, potentially improving patient outcomes.
What could go wrong: This is an observational study, not a treatment trial. It will not directly test any new therapy, and results may take years to influence clinical practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiovascular disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIOVASCULAR DISEASES PANVASCULAR DISEASES

Contacts and locations

Locations

Harbin Medical University
RECRUITING

Harbin, Heilongjiang, 150086, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.